You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

neratinib

Showing 1 - 25 of 58
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)

Recruiting
  • GastroEsophageal Cancer
  • Gastric Cancer
  • Neratinib
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Oct 25, 2023

Early-stage Breast Cancer, HER2 Positive Breast Cancer, Hormone Receptor Positive Trial (Neratinib, Loperamide, Colesevelam)

Not yet recruiting
  • Early-stage Breast Cancer
  • +2 more
  • Neratinib
  • +2 more
  • (no location specified)
Aug 5, 2022

Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer, Anatomic Stage III Breast Cancer Trial in United States

Not yet recruiting
  • Anatomic Stage I Breast Cancer
  • +3 more
  • Endocrine Therapy
  • +7 more
  • Atlanta, Georgia
  • +4 more
Jun 15, 2023

Breast Cancer, HER2-positive Breast Cancer Trial in Toronto (Neratinib)

Not yet recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • Neratinib
  • Toronto, Ontario, Canada
    University Health Network: Princess Margaret Cancer Centre
Oct 31, 2022

Treatment Patterns of Neratinib in HER2+ EBC in China

Not yet recruiting
  • Breast Cancer
  • Neratinib
  • Shanghai, China
    Medical Affair
Aug 4, 2022

Metastatic Prostate Adenocarcinoma, Castration-resistant Prostate Cancer, Prostate Cancer Trial in Boston (Neratinib)

Terminated
  • Metastatic Prostate Adenocarcinoma
  • +3 more
  • Neratinib
  • Boston, Massachusetts
  • +2 more
Jul 18, 2022

HER2 Amplified Breast Cancer Trial in Lisboa (Neratinib, Capecitabine, Loperamide)

Completed
  • HER2 Amplified Breast Cancer
  • Neratinib
  • +2 more
  • Lisboa, Portugal
    Hospital CUF Descobertas
Apr 4, 2022

HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,

Completed
  • HER2-positive Breast Cancer
  • +8 more
  • Neratinib
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Solid Tumor, Adult Trial in Richmond (Neratinib, Divalproex Sodium)

Recruiting
  • Solid Tumor, Adult
  • Neratinib
  • Divalproex Sodium
  • Richmond, Virginia
    Virginia Commonwealth University Massey Cancer Center
Mar 2, 2022

HER2-positive Breast Cancer Trial (Neratinib)

Not yet recruiting
  • HER2-positive Breast Cancer
  • Neratinib
  • (no location specified)
Nov 29, 2021

Breast Cancer Trial in United States (Neratinib, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Indianapolis, Indiana
  • +5 more
Mar 2, 2022

Breast Cancer, Brain Metastases Trial (Neratinib)

Withdrawn
  • Breast Cancer
  • Brain Metastases
  • Neratinib
  • (no location specified)
Feb 28, 2022

Breast Cancer, HER2-positive Breast Cancer, ER Positive Breast Cancer Trial (Neratinib, Letrozole (L) or Anastrozole (A),

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Neratinib
  • +2 more
  • (no location specified)
Jan 11, 2022

Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Breast Cancer Trial in United States (Capecitabine, Neratinib, EORTC QLQ - BR23, EQ-5D-5L, EORTC QLQ-C30)

Active, not recruiting
  • Breast Cancer
  • Hartford, Connecticut
  • +9 more
Apr 15, 2022

Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)

Not yet recruiting
  • Metastatic Breast Cancer
  • Breast Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 16, 2022

Stage IV (Metastatic) Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Boston (NERATINIB,

Not yet recruiting
  • Stage IV (Metastatic) Breast Cancer
  • +5 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 25, 2021

Advanced Breast Cancer Trial in Lebanon (Fulvestrant, Neratinib, Alpelisib)

Not yet recruiting
  • Advanced Breast Cancer
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center
Jun 28, 2023

Solid Tumor, CNS Tumor, Lymphoma Trial in Canada, United States (Neratinib)

Recruiting
  • Solid Tumor
  • +3 more
  • Neratinib
  • Phoenix, Arizona
  • +8 more
Mar 21, 2022

Colorectal Cancer Trial in United States (Cetuximab, Neratinib)

Withdrawn
  • Colorectal Cancer
  • Gainesville, Florida
  • +11 more
Oct 26, 2021

Metastatic Colorectal Cancer Trial in United States (Trastuzumab, Cetuximab, Neratinib)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Anaheim, California
  • +47 more
Mar 28, 2022

Glioblastoma Trial in United States (Temozolomide, Neratinib, QBS10072S)

Active, not recruiting
  • Glioblastoma
  • Birmingham, Alabama
  • +11 more
Aug 15, 2022

Breast Cancer Trial in Worldwide (Paclitaxel, Trastuzumab, Neratinib)

Completed
Has Results
  • Breast Cancer
  • Loma Linda, California
  • +41 more
Oct 4, 2021

Triple Negative Breast Cancer, Early-stage Breast Cancer, HER2-positive Breast Cancer Trial in Germantown (Neratinib)

Recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Neratinib
  • Germantown, Tennessee
    West Cancer Center
Oct 9, 2020

Early Stage HER2+ Breast Cancer Trial in Worldwide (Neratinib, Loperamide, Colestipol)

Completed
Has Results
  • Early Stage HER2+ Breast Cancer
  • Neratinib
  • +3 more
  • Birmingham, Alabama
  • +57 more
Apr 12, 2022